FIG. 8.
Quantitative reverse transcription polymerase chain reaction validation of gene expression changes of selected NF-κB target genes in untreated SKBR3 cells (Un) and cells treated with unlabeled trastuzumab (Tras), unlabeled trastuzumab-NLS-L (Tras-NLS), 111In-trastuzumab (111In-tras), and 111In-trastuzumab-NLS-L (111In-tras-NLS). Values show relative quantification in each group (n = 3/group) by biological grouping analysis when the expression level in Un is 1.